MEDNAX Profile

USD 0.11  0.19%

Sale by Joseph Calabro of 3000 shares of MEDNAX

MEDNAX Inc insider trading alert for sale of common stock by Joseph Calabro, PRES. & CHIEF OPERATING OFCR, on March 12, 2018. This event was filed by Mednax Inc with SEC on 2006-02-10. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

MEDNAX Summary

MEDNAX Inc (MD) is traded on New York Stock Exchange in USA. It is located in FLORIDA, U.S.A and employs 11,825 people. MEDNAX is listed under Healthcare category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with market capitalization of 5.34 B. MEDNAX Inc is active under Healthcare sector as part of Healthcare Services industry. This company has 92.76 M outstanding shares of which 6.26 M shares are now sold short in the market by investors with about 4.16 days to cover all shorted shares. Mednax reports about 70.49 M in cash with 403.12 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76.
Check MEDNAX Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected MEDNAX Inc Income Statement Over Time

Consolidated Income    Cost of Revenue    Earning Before Interest and Taxes EBIT    

Key Fundamentals

MEDNAX Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 42% 
Equity ratings for MEDNAX Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services in the United States and Puerto Rico. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida. MEDNAX operates under Specialized Health Services classification in USA and traded on New York Stock Exchange exchange. It employs 11825 people. more
Fama & French Healthcare
Fama & French Classification
CEO, DirectorRoger MedelView All
Thematic ClassificationHealthcareView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Healthcare Services
InstrumentUSA Stock View All
RegionNorth America
LocationFLORIDA, U.S.A
Business Address1301 Concord Terrace
Foreign Associate  Mexico
ExchangeNew York Stock Exchange
CIK Number00893949.0
IndustryHealthcare Services
Contact Number954 384 0175
Related EntityPDX
CurrencyUSD - US Dollar


MEDNAX Analyst Recommendations
Target PriceAdvice# of Analysts
MEDNAX Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
MEDNAX Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


MEDNAX Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.82April 27, 2017
MEDNAX Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


MEDNAX Corporate Directors
Enrique Sosa Independent Director, Ph.D
Waldemar Carlo Independent Director
Paul Gabos Independent Director